Catalyst Funds Management Pty Ltd Buys 2,400 Shares of The Clorox Company (NYSE:CLX)

Catalyst Funds Management Pty Ltd increased its stake in The Clorox Company (NYSE:CLX) by 600.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,800 shares of the company’s stock after buying an additional 2,400 shares during the period. Catalyst Funds Management Pty Ltd’s holdings in Clorox were worth $455,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CLX. Greatmark Investment Partners Inc. purchased a new position in shares of Clorox in the 4th quarter valued at approximately $316,000. LBP AM SA lifted its position in Clorox by 212.8% during the fourth quarter. LBP AM SA now owns 84,122 shares of the company’s stock valued at $13,662,000 after buying an additional 57,228 shares during the period. Skandinaviska Enskilda Banken AB publ boosted its holdings in shares of Clorox by 29.4% during the 4th quarter. Skandinaviska Enskilda Banken AB publ now owns 43,107 shares of the company’s stock valued at $6,958,000 after buying an additional 9,800 shares in the last quarter. Avantax Advisory Services Inc. grew its position in shares of Clorox by 6.3% in the 4th quarter. Avantax Advisory Services Inc. now owns 15,510 shares of the company’s stock worth $2,519,000 after buying an additional 920 shares during the period. Finally, Essential Planning LLC. bought a new position in shares of Clorox in the 4th quarter worth about $515,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Up 0.3 %

CLX stock opened at $147.32 on Friday. The company has a market cap of $18.15 billion, a price-to-earnings ratio of 40.25, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The business’s 50-day moving average is $154.20 and its two-hundred day moving average is $160.20. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business earned $2.16 EPS. As a group, analysts forecast that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 annualized dividend and a dividend yield of 3.31%. Clorox’s payout ratio is 133.33%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on CLX shares. Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. JPMorgan Chase & Co. upped their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. StockNews.com lowered Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. DA Davidson dropped their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating on the stock in a report on Wednesday, February 5th. Finally, Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has given a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $159.62.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.